{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Phosphate+buffered+saline+%28PBS%29&page=2", "query": { "intervention": "Phosphate buffered saline (PBS)", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 70, "total_pages": 7, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Phosphate+buffered+saline+%28PBS%29&page=3&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Phosphate+buffered+saline+%28PBS%29&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-06T11:39:29.135Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00694213", "title": "Pandemic Influenza Plasmid DNA Vaccines (Needle-Free)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Influenza" ], "interventions": [ { "name": "VCL-IPM1", "type": "BIOLOGICAL" }, { "name": "VCL-IPT1", "type": "BIOLOGICAL" }, { "name": "PBS", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Vical", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 47, "start_date": "2007-08", "completion_date": "2011-02", "has_results": false, "last_update_posted_date": "2019-02-27", "last_synced_at": "2026-10-06T11:39:29.135Z", "location_count": 3, "location_summary": "San Diego, California • Baltimore, Maryland • Stony Brook, New York", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Stony Brook", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00694213" }, { "nct_id": "NCT01171469", "title": "Vaccination With Dendritic Cells Loaded With Brain Tumor Stem Cells for Progressive Malignant Brain Tumor", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Brain Tumor", "Glioblastoma", "Medulloblastoma", "Ependymoma", "Anaplastic Astrocytoma" ], "interventions": [ { "name": "Dendritic Cells", "type": "BIOLOGICAL" }, { "name": "Imiquimod", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "Masonic Cancer Center, University of Minnesota", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 8, "start_date": "2010-09", "completion_date": "2012-06", "has_results": false, "last_update_posted_date": "2017-12-02", "last_synced_at": "2026-10-06T11:39:29.135Z", "location_count": 1, "location_summary": "Minneapolis, Minnesota", "locations": [ { "city": "Minneapolis", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT01171469" }, { "nct_id": "NCT00768066", "title": "The Transendocardial Autologous Cells (hMSC or hBMC) in Ischemic Heart Failure Trial (TAC-HFT)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Stem Cell Transplantation", "Ventricular Dysfunction, Left" ], "interventions": [ { "name": "Autologous human mesenchymal cells (hMSCs)", "type": "BIOLOGICAL" }, { "name": "Autologous human bone marrow cells (hBMCs)", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "University of Miami", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "21 Years to 90 Years" }, "enrollment_count": 65, "start_date": "2008-08", "completion_date": "2013-09", "has_results": true, "last_update_posted_date": "2015-12-14", "last_synced_at": "2026-10-06T11:39:29.135Z", "location_count": 1, "location_summary": "Miami, Florida", "locations": [ { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00768066" }, { "nct_id": "NCT01753830", "title": "Durolane Versus Phosphate Buffered Saline (PBS) in Knee Osteoarthritis", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Knee Osteoarthritis" ], "interventions": [ { "name": "Durolane", "type": "DEVICE" }, { "name": "PBS", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Galderma R&D", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "40 Years to 80 Years" }, "enrollment_count": 75, "start_date": "2012-12", "completion_date": "2014-02", "has_results": true, "last_update_posted_date": "2022-08-26", "last_synced_at": "2026-10-06T11:39:29.135Z", "location_count": 25, "location_summary": "Anniston, Alabama • Mobile, Alabama • Phoenix, Arizona + 22 more", "locations": [ { "city": "Anniston", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Hot Springs", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01753830" }, { "nct_id": "NCT00709800", "title": "Pandemic Influenza Plasmid DNA Vaccines (Needle)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Influenza" ], "interventions": [ { "name": "VCL-IPT1", "type": "BIOLOGICAL" }, { "name": "VCL-IPM1", "type": "BIOLOGICAL" }, { "name": "PBS", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Vical", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 56, "start_date": "2007-08", "completion_date": null, "has_results": false, "last_update_posted_date": "2009-02-12", "last_synced_at": "2026-10-06T11:39:29.135Z", "location_count": 3, "location_summary": "San Diego, California • Baltimore, Maryland • Stony Brook, New York", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Stony Brook", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00709800" }, { "nct_id": "NCT06193031", "title": "A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of C16TR for Inhalation With Tyvaso® Cohort in Healthy Participants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Volunteers" ], "interventions": [ { "name": "C16TR", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Tyvaso®", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Insmed Incorporated", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 24, "start_date": "2015-11-17", "completion_date": "2015-12-18", "has_results": false, "last_update_posted_date": "2024-01-05", "last_synced_at": "2026-10-06T11:39:29.135Z", "location_count": 1, "location_summary": "Los Angeles, California", "locations": [ { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06193031" }, { "nct_id": "NCT01556945", "title": "Safety and Preliminary Efficacy of the Malaria Vaccine Candidates Falciparum Merozoite Protein-1 (FMP1) and SmithKlineBeecham (SKBB) Candidate Malaria Vaccine RTS,S", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Malaria, Falciparum" ], "interventions": [ { "name": "FMP1/AS02", "type": "BIOLOGICAL" }, { "name": "RTS,S/AS02", "type": "BIOLOGICAL" }, { "name": "AS02 adjuvant alone", "type": "OTHER" }, { "name": "Malaria challenge", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "U.S. Army Medical Research and Development Command", "sponsor_class": "FED", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 72, "start_date": "2001-04", "completion_date": null, "has_results": false, "last_update_posted_date": "2014-05-02", "last_synced_at": "2026-10-06T11:39:29.135Z", "location_count": 1, "location_summary": "Silver Spring, Maryland", "locations": [ { "city": "Silver Spring", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT01556945" }, { "nct_id": "NCT06504160", "title": "Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Atopic Dermatitis" ], "interventions": [ { "name": "ShA9 Topical Gel", "type": "DRUG" }, { "name": "Hydrocortisone Ointment", "type": "DRUG" }, { "name": "Clobetasol Ointment", "type": "DRUG" }, { "name": "Fluocinonide Ointment", "type": "DRUG" }, { "name": "Placebo (Vehicle) Topical Gel", "type": "DRUG" }, { "name": "Triamcinolone Ointment", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": null, "sex": "ALL", "summary": "6 Years and older" }, "enrollment_count": 86, "start_date": "2025-05-22", "completion_date": "2027-02-05", "has_results": false, "last_update_posted_date": "2026-07-02", "last_synced_at": "2026-10-06T11:39:29.135Z", "location_count": 8, "location_summary": "San Diego, California • Denver, Colorado • Chicago, Illinois + 4 more", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Chicago", "state": "Illinois" }, { "city": "New York", "state": "New York" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT06504160" }, { "nct_id": "NCT02187003", "title": "Efficacy and Safety of Rivipansel (GMI-1070) in the Treatment of Vaso-Occlusive Crisis in Hospitalized Subjects With Sickle Cell Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Anemia, Sickle Cell" ], "interventions": [ { "name": "Rivipansel", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Biossil Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": null, "sex": "ALL", "summary": "6 Years and older" }, "enrollment_count": 345, "start_date": "2015-06-17", "completion_date": "2019-06-27", "has_results": true, "last_update_posted_date": "2025-03-11", "last_synced_at": "2026-10-06T11:39:29.135Z", "location_count": 126, "location_summary": "Mobile, Alabama • Little Rock, Arkansas • Oakland, California + 40 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Oakland", "state": "California" }, { "city": "Sacramento", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02187003" }, { "nct_id": "NCT01765426", "title": "Phase 1b Study Investigating Safety & Immunogenicity of TDV Given Intradermally by Needle or Needle-Free PharmaJet Injector", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Volunteers" ], "interventions": [ { "name": "TDV", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "Takeda", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 67, "start_date": "2013-02-15", "completion_date": "2014-06-26", "has_results": true, "last_update_posted_date": "2019-07-18", "last_synced_at": "2026-10-06T11:39:29.135Z", "location_count": 2, "location_summary": "Galveston, Texas • Seattle, Washington", "locations": [ { "city": "Galveston", "state": "Texas" }, { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT01765426" } ] }